Meet T-CURX' CEO Ulf Grawunder at the 26th SACHS Annual Biotech in Europe Forum

T-CURX CEO, Ulf Grawunder, PhD, will attend SACHS ASSOCIATES' 26th Annual Biotech in Europe Forum, taking place from October 7-8, 2026 at the Mövenpick Hotel in Basel, Switzerland.

This established global biopharma industry event will address the key challenges and investment trends for 2026, with a strong focus on partnering, alliance management, and future prospects. Ulf will present an update on T-CURX CAR-T development activities at a presentation on DAY 1 of the conference, 4:15 p.m. CET as part of PR Track D and will also join a panel discussion on "Advanced Oncology Investment" on DAY 2 starting at 1 p.m. CET.

For more information on this congress, please visit the conference's website at:

https://sachsforum.com/events/26th-bef